Specific weight Size Plasma1,0261-4 μm Platelets1,0406-10 μm Lymphocytes1,07710-30 μm...
-
Upload
shauna-kelly -
Category
Documents
-
view
222 -
download
3
Transcript of Specific weight Size Plasma1,0261-4 μm Platelets1,0406-10 μm Lymphocytes1,07710-30 μm...
Apheresis
Supervisor :
Present by:
Mr. Ghorbani
Ehsan Masjedi
Outline
What’s?! What is advantage ? Mechanism Types
What’s that?!
Apheresis:Derives from Greek,
A technique in which whole blood is taken and separated
History of Apheresis
Hippocrates; 460 – 377 bc
History of Apheresis
History of Apheresis
History of Apheresis
Tuesday, 9 April, 13
Use of Apheresis
Donor facilitate collection
Therapy removing undesired substances
Mecanism
Centrifuge Filteration Adsorption
The main base
centrifuge
The main base
Specific weight
Size
Plasma 1,026 1-4 μm
Platelets 1,040 6-10 μm
Lymphocytes 1,077 10-30 μm
Monocytes 1,080 10-15 μm
Eosinophils 1,082 9-15 μm
Neutrophils 1,088 12-15 μm
Erytrocytes 1,100 6-8 μm
The main base
Continuous flow centrifuges ( CFC )
Intermittent flow centrifuges ( IFC )
Filteration
AdsorptionChromatography
• Pathogenic Ab • LDL • Immune complexes• Bile acids• …
• Staphylococcal A proteins• Dextran sulfate• Anti bodies• Charchol• …
Adsorption Staphylococcal A proteins
Dextran sulfate
IgG 1, 2, 4 Types of immune complexes containing Trombocytopeny refractory autoimmune
Familial Hypercholesterolemia
Extracorporeal photopheresis (ECP)
• Uv• 8MOP ( 8 met oxy psoralens )• CTCL ( cutaneous T cell lymphoma )• Autoimmune Diseases• GVHD (Graft-versus-host disease )
RBC exchange Leukocytapheresis Extracorporeal photopheresis Platelet apheresis Thrombocytapheresis Erythrocytapheresis
Plasmapheresis LDL apheresis Plasma exchange
cytopheresis
plasmapheresis
Crystalloid Albumin 5% FFP colloidal Starch ( 3-6 % )
Replacement fluids
Anticoagulants ACP ( acid citrate dextrose ) Heparin
• Category I• Category II • Category III • Category IV
American Society for Apheresis ( ASFA )
Acute inflammatory demyelinating polyneuropathy (Guillain-Barré syndrome) (plasma exchange) • ANCA-associated rapidly progressive glomerulonephritis (Wegener’s Granulomatosis) (plasma exchange) • Anti-glomerular basement membrane disease (Goodpasture’s syndrome) (plasma exchange) • Babesiosis (RBC exchange) • Cardiac allograft rejection prophylaxis (photopheresis) • Chronic inflammatory demyelinating polyneuropathy (plasma exchange) • Cryoglobulinemia (plasma exchange) • Cutaneous T-cell lymphoma; mycosis fungoides; Se´zary syndrome, erythrodermic (photopheresis) • Homozygous familial hypercholesterolemia (plasma exchange or selective adsorption) • Hyperleukocytosis, leukostasis (leukocytapheresis) • Hyperviscosity in monoclonal gammopathies, treatment of symptoms (plasma exchange) • IgG/IgA, or IgM type of paraproteinemic polyneuropathy (plasma exchange) • Myasthenia gravis (plasma exchange) • Renal transplantation, antibody mediated rejection (plasma exchange) • Sickle cell disease: red blood cell exchange for acute stroke • Thrombotic thrombocytopenic purpura (plasma exchange)
Cate
gory
1
• Grade 1A: Strong recommendation, high-quality evidence • Grade 1B: Strong recommendation, moderate quality evidence • Grade 1C: Strong recommendation, low-quality or very low-quality evidence • Grade 2A: Weak recommendation, high quality evidence • Grade 2B: Weak recommendation, moderate quality evidence • Grade 2C: Weak recommendation, low-quality or very low-quality evidence
American Society for Apheresis ( ASFA )
Yt = Y0 e-x
Single-compartment model of plasma exchange
Concentration-time
The initial concentration
Plasma volume replacement in time
Citrate toxicity Allergic reactions Anaphylactoid reactions Infection Deletion of drugs Anemia & hemolysis Hypotermia Hypovolumy
Side effects
سکوتچند خط ...... باالتر از هزار حرف نگفته ما
... به امید روزی که همه مشکالت و تبعیض ها برطرف بشه... باید بخواهیم ... و برایش تالش و ایثار کنیم
احسان مسجدی کارشناس علوم آزمایشگاهی
کپی برداری و استفاده از این پاورپوینت برای!دانشجویان علوم آزمایشگاهی آزاد است
( زکات علم یاد دادنش به دیگرانه )!ولی اگه تونستین از من هم اسمی ببرید
Thanks for your attention!